[Response of bladder cancer to radiotherapy from the histological viewpoint].
D000230:Adenocarcinoma / Q000532:radiotherapy; D000368:Aged; D001808:Blood Vessels / Q000528:radiation effects*; D002277:Carcinoma / Q000532:radiotherapy; D002291:Carcinoma, Papillary / Q000532:radiotherapy; D002294:Carcinoma, Squamous Cell / Q000532:radiotherapy; D003036:Cobalt Isotopes; D003556:Cystitis / Q000150:complications; D004307:Dose-Response Relationship, Radiation; D006801:Humans; D010689:Phlebitis; D011379:Prognosis; D011830:Radiation Effects; D011867:Radioisotope Teletherapy; D011879:Radiotherapy Dosage; D011882:Radiotherapy, High-Energy; D001743:Urinary Bladder / Q000098:blood supply; D001749:Urinary Bladder Neoplasms / Q000150:complications / Q000473:pathology / Q000532:radiotherapy*
D003036:Cobalt Isotopes
Das Verhalten des Harnblasenkarzinoms während der Strahlentherapie nach histologischen Kriterien.